Annals of Vascular Surgery

, Volume 10, Issue 1, pp 16–21 | Cite as

Protective effect of a platelet-activating factor antagonist (WEB-2086) in postischemic renal failure

  • Jose A. González-Fajardo
  • Leopoldo Fernandez
  • Tomas Alvarez
  • Beatriz Aguirre
  • Guillermo Ramos
  • Carlos Vaquero
Original Articles


The purpose of this study was to evaluate the renoprotective effect of a specific platelet-activating factor antagonist (WEB-2086) in an experimental model of normothermic renal ischemia. Twenty New Zealand white rabbits were studied for 2 days before and 24 hours after a 60-minute period of renal ischemia induced by bilateral clamping of the renal arteries. The animals were divided into two groups: a control group (group A; n=10) and a treated group (group B; n=10). In group A the urinary flow rate decreased significantly (from 0.098±0.008 ml/min to 0.029±0.005 ml/min) (p<0.001) and there was a significant reduction in creatinine clearance (from 11.4±1.2 ml/min to 3.4±1.1 ml/min) (p<0.001). In group B no significant changes were observed, although the urinary flow rate increased even in the postischemic period (from 0.09±0.008 ml/min to 0.11±0.02 ml/min). Microcirculatory cortical flow showed a postischemic reduction in both groups, although it was most significant in the control group (group A=43.7%, group B=71.5%;p<0.001). Histologic study showed mild damage with patchy tubular necrosis in both groups, although this injury was less severe in the treated group. The results suggest that the preoperative administration of WEB-2086 produces a potent diuretic effect with significant attenuation of postischemic acute renal failure.


Renal Failure Renal Artery Acute Renal Failure Creatinine Clearance Histologic Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Miller DC, Myers BD. Pathophysiology and prevention of acute renal failure associated with thoracoabdominal or abdominal aortic surgery. J Vasc Surg 1987;5:518–523.CrossRefPubMedGoogle Scholar
  2. 2.
    Lopez-Farre A, Torralbo M, Lopez-Novoa JM. Glomeruli from ischemic rat kidneys produce increased amounts of platelet activating factor. Biochem Biophys Res Commun 1988;152:129–135.CrossRefPubMedGoogle Scholar
  3. 3.
    Lopez-Farre A, Gomez-Garre D, Bernabeu F, et al. A role for endothelin in the maintenance of postischemic renal failure in the rat. J Physiol 1991;444:513–522.PubMedGoogle Scholar
  4. 4.
    Schlondorff D, Goldwasser P, Neuwirth R, et al. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells. Am J Physiol 1986;250:F1123-F1127.PubMedGoogle Scholar
  5. 5.
    Caramelo C, Fernandez-Gallardo S, Marin-Cao D, et al. Presence of platelet activating factor in blood from humans and experimental animals. Its absence in anephric individuals. Biochem Biophys Res Commun 1984;120:789–796.CrossRefPubMedGoogle Scholar
  6. 6.
    Schlondorff D, Neuwirth R. Platelet-activating factor and the kidney. Am J Physiol 1986, 251:F1-F11.PubMedGoogle Scholar
  7. 7.
    Myers BD, Moran SM. Hemodynamically mediated acute renal failure. N Engl J Med 1986;314:97–105.PubMedCrossRefGoogle Scholar
  8. 8.
    Brezis M, Rosen S, Silva P, et al. Renal ischemia: A new perspective. Kidney Int 1984;26:375–383.PubMedCrossRefGoogle Scholar
  9. 9.
    Abbott WM, Austen WG. The reversal of renal cortical ischemia during aortic occlusion by mannitol. J Surg Res 1974;16:482–489.CrossRefPubMedGoogle Scholar
  10. 10.
    McDougal WS. Renal perfusion/reperfusion injuries. J Urol 1988;140:1325–1330.PubMedGoogle Scholar
  11. 11.
    Dworkin LD, Brenner BM. Biophysical bases of glomerular filtration. In Seldin DW, Giebisch G, eds. The Kidney: Physiology and Pathophysiology. New York: Raven, 1985, pp 397–426.Google Scholar
  12. 12.
    Schlondorff D, Satriano JA, Hagege J, et al. Effect of platelet-activating factor and serum-treated zymosan on prostaglandin E2 synthesis, arachidonic acid release and contraction of cultured rat mesangial cells. J Clin Invest 1984;73:1227–1231.PubMedCrossRefGoogle Scholar
  13. 13.
    Scharschmidt LA, Douglas JG, Dunn MJ. Angiotensin II and eicosanoids in the control of glomerular size in the rat and humans. Am J Physiol 1986;250:F348-F356.PubMedGoogle Scholar
  14. 14.
    Duque I, Garcia-Escribano C, Rodriguez-Puyol M, et al. Effects of reactive oxygen species on cultured rat mesangial cells and isolated rat glomeruli. Am J Physiol 1992;263:F466-F473.PubMedGoogle Scholar
  15. 15.
    Lopez-Farre A, Gomez-Garre D, Bernabeu F, et al. Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF. Kidney Int 1991;39:624–630.PubMedCrossRefGoogle Scholar

Copyright information

© Annals of Vascular Surgery Inc 1996

Authors and Affiliations

  • Jose A. González-Fajardo
    • 1
  • Leopoldo Fernandez
    • 1
  • Tomas Alvarez
    • 1
  • Beatriz Aguirre
    • 1
  • Guillermo Ramos
    • 1
  • Carlos Vaquero
    • 1
  1. 1.Division of Vascular SurgeryHospital Universitario ValladolidValladolidSpain

Personalised recommendations